10 Aug 2022 , 11:03 AM
The company reported total revenue of Rs1,156.90 crore in Q1FY23, registering a growth of 39.20% yoy. Sequentially, revenue grew by 9.7% on the back of improved sales mix and realizations.
Company’s EBITDA for Q1FY23 stood at Rs146 crore, registering a y-o-y growth of 29.20%, while remaining flat on a quarterly basis.
Galaxy Surfactants achieved the highest-ever quarterly PAT at Rs100.40 crore in Q1FY23, up by 30.70% yoy, and 2% sequentially.
Company’s total volumes stood at 55,272 MT for Q1FY23, down 7.7% yoy basis and 3.9% on a QoQ basis.
While demand side risks had an impact on the company’s volumes, a healthy mix and leveraging on emerging opportunities ascertained the highest profitability in this quarter.
As previously stated, FY23 will be all about handling supply and demand risks. While supply-side factors improved this quarter, they are still not back to pre-pandemic levels, stated the company.
The European energy crisis and the impending slowdown continue to be a source of concern and risk for the company’s specialty care products in the future.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.